Related by context. All words. (Click for frequent words.) 77 Entereg TM 75 alvimopan 73 FOLOTYN ® 72 XL# anticancer compounds 72 severe gastroparesis 72 oral prodrug 71 GEM OS2 71 Pivotal Phase III 71 opioid induced bowel dysfunction 71 acetonide FA 71 Zenvia ™ 71 refractory gout 71 Crofelemer budesonide foam 71 MAGE A3 ASCI 71 TRIOLEX HE# APOPTONE HE# 70 postoperative ileus POI 70 Xcytrin R 70 Panzem R 70 PDX pralatrexate 70 Meets Primary Endpoint 70 catheter occlusion 70 vapreotide acetate 70 Personalized Immunotherapy 70 Completes Patient Enrollment 70 Oracea TM 70 CYT# potent vascular disrupting 70 delivers fluocinolone acetonide FA 70 gastrointestinal mucositis 70 mocetinostat MGCD# 70 FOLFOX6 chemotherapy regimen 70 CORLUX CORT # 70 GERD migraine headaches 70 Telik logo TELINTRA 69 opioid bowel dysfunction 69 post operative ileus 69 Anturol 69 XL# XL# XL# 69 Pivotal Phase 69 Initiates Enrollment 69 R lenalidomide 69 Phase 2b Clinical Trial 69 lintuzumab SGN 69 TRANSDUR ® 69 Ophena TM 69 includes TOLAMBA TM 69 AzaSite Plus 69 ENTEREG ® 69 methylnaltrexone bromide 69 Anturol TM 69 Oral Calcitonin 69 R Saizen R 69 ocular formulation 69 CRMD# 69 MOVIPREP R 69 Budesonide foam crofelemer 69 CD# CEA 69 including eniluracil ADH 69 SinuNase TM 69 vaginally administered lidocaine 69 interferon gamma 1b 69 Serostim ® 69 SPRYCEL ® 69 ospemifene 69 Demonstrates Positive 69 lucinactant 69 LEP ETU 68 albiglutide 68 XP# XP# 68 Evoltra ® 68 Pafuramidine 68 dextromethorphan quinidine 68 treat dysmenorrhea 68 Phenoptin 68 mGluR5 NAM 68 docetaxel Taxotere ® 68 Receives Orphan Drug 68 R sorafenib tablets 68 CB2 selective receptor agonist 68 candidate XP# 68 #CL# 68 Initiates Phase II 68 hyperphenylalaninemia HPA due 68 Gel repository corticotropin injection 68 markets COLAZAL 68 severe hypersensitivity reactions 68 oxymorphone ER 68 diarrhea predominant irritable 68 Augment TM 68 elotuzumab 68 Cellegesic 68 adenosine injection 68 Initiates Clinical 68 Fibrillex TM 68 virus HCV protease inhibitor 68 investigational humanized monoclonal antibody 68 sorafenib tablets 68 induced macular edema 68 novel histone deacetylase 68 ACTEMRA TM 68 prokinetic agent 68 CTAP# Capsules 68 painful diabetic neuropathy 68 Romiplostim 68 alpha interferons 68 sodium thiosulfate STS 68 Phase IIb Clinical Trial 68 Phase III Pivotal 67 Granted Orphan Drug 67 headache nasopharyngitis 67 INSPIRE Trial Phase III 67 brand ciclesonide HFA 67 Glufosfamide 67 sapropterin dihydrochloride Tablets 67 LibiGel ® 67 Lenocta TM 67 Solazed TM 67 selective androgen receptor modulator 67 sapropterin dihydrochloride 67 PROVENGE ® 67 PANVAC VF 67 TYZEKA 67 galiximab 67 DURECT proprietary 67 TRANSDUR ™ 67 ThermoDox ® clinical 67 Presents Positive 67 Exelixis compounds 67 GATTEX TM 67 Golimumab 67 ELADUR TM 67 treat chronic sinusitis 67 forodesine 67 pseudobulbar affect PBA 67 ularitide 67 S1P antibody 67 BCG refractory carcinoma 67 nephropathic cystinosis cystinosis 67 Cleviprex TM clevidipine 67 miconazole MBT 67 CINTREDEKIN BESUDOTOX 67 Achieves Primary Endpoint 67 pentadentate logo R 67 developing ostarine selective 67 novel VDA molecule 67 myelodysplastic myeloproliferative diseases 67 Prestara TM 67 successfully commercialize Iluvien 67 PNP inhibitor 67 DDP# 67 #D#C# 67 Disease IBD 67 personalized cellular immunotherapy 67 Receives Orphan Drug Designation 67 LymphoStat B belimumab 67 tiapamil 67 SILENOR 67 Aurexis 67 pralatrexate injection folate analogue 67 Cinryze TM 67 gastrointestinal disorders ATI 67 gastrointestinal disorders characterized 67 nonhematologic adverse reactions 67 Tezampanel 67 Veronate R 67 Diabetic Macular Edema 67 kidney urologic 67 Elagolix 67 HEPLISAV TM 67 HGS ETR2 67 6R BH4 67 RAPTIVA 67 metaglidasen 67 IMiDs 67 Oral Fingolimod 67 markets HP Acthar 67 Pivotal Trial 67 evaluating picoplatin 67 severe hypercholesterolemia 67 ALN PCS 67 XL# XL# XL# XL# 67 JAK2 Inhibitor 67 selective A2A adenosine receptor 67 CINQUIL 67 diabetic neuropathic pain 67 Amigal TM 67 Fludara ® 67 ELADUR ™ 67 Zorbtive TM 66 PRT# 66 valtorcitabine 66 cMET 66 IMiDs ® compound 66 herpetic keratitis 66 urocortin 2 66 Ovitrelle R Serostim 66 cannabinor 66 include PLX IBD 66 evaluating tivozanib 66 subsidiaries visit http:/www.apricusbio.com 66 ® bortezomib 66 Kuvan R 66 First Patient Enrolled 66 Zemiva ™ 66 HepeX B TM 66 palonosetron hydrochloride injection 66 TO AVOID PREGNANCY WHILE 66 Known hypersensitivity 66 POSIDUR TM 66 receptor tyrosine kinase inhibitor 66 refractory chronic lymphocytic 66 markets Gelclair R 66 R metformin Concor 66 IONSYS TM 66 candidates Azedra TM 66 TELINTRA 66 ruxolitinib 66 HGS ETR1 mapatumumab 66 Initiate Phase 66 5 lipoxygenase inhibitor 66 intravenous methylnaltrexone 66 dasatinib Sprycel ® 66 post herpetic neuralgia PHN 66 markets Testim ® 66 pain palliation 66 hypoxia activated prodrug 66 TORISEL 66 THR beta agonist 66 ALN HPN 66 Begins Dosing 66 Oral NKTR 66 metastatic GIST 66 Cardium Therapeutics TM 66 Plaque Psoriasis 66 ADL# novel 66 Completes Enrollment 66 GATTEX ™ 66 osteoarthritis rheumatoid arthritis 66 modified glutathione analog 66 erlotinib Tarceva R 66 Xanafide 66 HCl PEPCID ® famotidine 66 Submits NDA 66 oral picoplatin 66 Mg Usa 66 Initiates Phase III 66 esophageal candidiasis 66 bazedoxifene conjugated estrogens 66 pan histone deacetylase 66 Randomized Double blind 66 R bisoprolol Euthyrox 66 ADP receptor antagonist 66 neuropathic pain spasticity 66 Serostim R 66 IV APAP 66 Initiates Clinical Trial 66 Serious adverse reactions 66 UPLYSO 66 CIMZIA TM certolizumab pegol 66 cystinosis patients 66 Vicriviroc 66 Intravitreal injections 66 retinal vein occlusion induced 66 Adentri 66 molecular imaging radiopharmaceutical 66 MCSP respectively 66 aripiprazole Abilify 66 Pegloticase 66 Hematide ™ 66 investigational monoclonal antibody 66 Phase 2b Trial 66 SILENOR TM 66 targeting Inflammatory Bowel 66 systemic immunosuppressive drugs 66 drug ISA# 66 Allovectin 7 R 66 Syndrome RLS 66 2 methoxyestradiol 66 Phase III Clinical Trial 66 orally administered inhibitor 66 Zemiva TM 66 DNA methyltransferase inhibitors 66 highly purified pasteurized 66 Cannabinor 66 Microplasmin 66 Prestara 66 Erythropoietic therapies may 66 AVASTIN 66 visilizumab 66 PREOS R 66 investigational pharmacologically unique 66 MEK Inhibitor 66 mecarbil 66 DIFICID ™ 66 Patient Enrollment 66 Lupus Nephritis 66 Dual Opioid 66 Archexin 66 mGluR5 negative 65 Stedivaze 65 trastuzumab DM1 T DM1 65 Initiate Phase III 65 signal detection CTSD 65 Phase IIb Trial 65 docetaxel Taxotere R 65 cardiometabolic diseases Glucophage 65 Aloxi ® 65 Augment Injectable 65 Lixivaptan 65 rheumatoid arthritis psoriatic arthritis 65 Trial Evaluating 65 NDA Submission 65 neutropenia dehydration dyspnea 65 developing ACAPODENE 65 recurrent metastatic ovarian cancer 65 hoFH 65 dyslipidemia hypertension diabetes 65 peripherally acting 65 Files IND 65 antiarrhythmic drug 65 Entereg 65 OMNARIS Nasal Spray 65 BENLYSTA ® 65 Demonstrates Significant 65 STELARA TM 65 pyrexia mucositis sepsis febrile 65 somatropin Kuvan R 65 Allovectin 7 r 65 OMNARIS HFA 65 opioid induced 65 XIAFLEX ® 65 Luveris R Ovidrel R 65 IMiDs R 65 ILUVIEN ® 65 acyclovir Lauriad R 65 CCX# B 65 oral ridaforolimus 65 Aryplase 65 octreotide implant 65 BEMA Granisetron 65 JAK inhibitor 65 Pruvel 65 formerly LymphoStat B 65 Panzem R NCD 65 VIVITROL ® 65 forodesine hydrochloride 65 OAB overactive bladder 65 inhibitor PPI 65 Dyloject TM 65 phase III isavuconazole 65 Presents Preclinical Data 65 Aflibercept 65 AzaSite TM 65 Phase Ib clinical trials 65 include Phenoptin TM 65 Dacogen injection 65 oral antidiabetic medication 65 zolpidem tartrate sublingual tablet 65 dihydrochloride Tablets 65 Successfully Completes Phase 65 Zoraxel 65 Auxilium anticipates 65 ONTAK 65 HuMax EGFr 65 faropenem medoxomil 65 Neulasta R 65 Simulect 65 Solzira TM 65 diarrhea fatigue asthenia 65 migraine headaches neuropathic pain 65 ARIKACE ™ 65 Hsp# Inhibitor 65 TELCYTA 65 diabetic peripheral neuropathic DPN 65 sapacitabine CYC# 65 non constipation irritable 65 PRN FDA Approves 65 AAG geldanamycin analog 65 PROMACTA 65 oral nucleoside analogue 65 investigational antiplatelet agent 65 systemically administered 65 erlotinib Tarceva ® 65 carcinoid syndrome 65 Bicifadine 65 riociguat 65 R MSCRAMM 65 Zingo TM 65 Xeloda ® 65 MAA submission 65 Presents Preclinical 65 vernakalant oral 65 COLAZAL R 65 ARCOXIA 65 Dementia Related Psychosis 65 inflammatory autoimmune diseases 65 XL# XL# 65 R#/MEM # 65 Selzentry Celsentri 65 cardiac myosin activator omecamtiv 65 Tekamlo 65 Genasense ® oblimersen 65 PRIMO CABG2 65 ® decitabine 65 VISICOL R 65 SYCREST 65 generation purine nucleoside 65 polyneuropathy HIV DSP 65 Linjeta TM 65 developing Bicifadine serotonin 65 dyskinesia PD LID 65 non metastatic osteosarcoma 65 Initiate Clinical Trial 65 Sudhir Agrawal D.Phil 65 PEGINTRON TM 65 candidate CRLX# 65 LEUKINE 65 Romidepsin 65 torsemide ER 65 Novel Oral 65 leading oral taxane 65 LHRH antagonists 65 EDEMA3 trial 65 Iluvien ® 65 rasagiline tablets 65 novel synthetic PEGylated 65 Androxal TM 65 Prodarsan R 65 Lubiprostone 65 Somatuline R Depot 65 Friedreich Ataxia FRDA 65 mGluR2 positive 65 SEROQUEL R 65 MERLIN TIMI 65 FavId 65 receiving XGEVA 65 transthyretin mediated amyloidosis ATTR 65 Tasimelteon 65 Navelbine ® 65 HMG CoA reductase inhibitors 65 Epratuzumab 65 RHUCIN 65 product platforms AZX# 65 VEGFR2 inhibitor 65 Hedgehog Pathway Inhibitor 65 PEGylated interferon beta 1a 65 Efficacy Results 65 BRILINTA 65 fosbretabulin 65 Octreolin 65 MGN# 65 ALVESCO ® 65 generation DACH Platinum 65 LE SN# 65 GTC recombinant human 65 vidofludimus 65 Kosan dependence 65 huC# DM4 65 bone marrow reticulin deposition 65 Civacir 64 Alseres Cethrin 64 CORT # 64 SUSTENNA TM 64 Raptiva R 64 Fx #A 64 Pazopanib 64 Troxatyl 64 lexidronam injection 64 Anturol ® 64 Reports Preclinical Data 64 SUPPRELIN R LA 64 IL# PE#QQR 64 Receives Fast Track 64 naronapride 64 LEVAQUIN ® 64 RSD# oral 64 Cetrorelix 64 MKC# MKC# PP 64 CCR5 mAb 64 PXD# 64 Besivance 64 Investigational Treatment 64 Fast Track designations 64 IMPACS R 64 TLK# 64 RoACTEMRA 64 ACTIQ ® 64 Contrave# 64 PrevOnco 64 syndrome overactive bladder 64 Ticagrelor 64 Dupuytren Disease 64 TBC# 64 Study Evaluating 64 vaginal candidiasis 64 diabetic gastroparesis 64 compound INCB# 64 Pirfenidone 64 GEM OS1 64 PI3K/Akt pathway inhibitor 64 toenail onychomycosis 64 Aeolus Pharmaceuticals Announces 64 Major Depressive Disorder MDD 64 Coadministration 64 SNT MC# 64 Initiates Phase 64 Methylnaltrexone 64 BiovaxID TM 64 Shows Statistically Significant 64 pharmacogenomic translational research 64 Vidaza ® 64 postoperative ileus 64 myopathy rhabdomyolysis 64 Afatinib 64 HCD# [002] 64 Gemzar ® 64 INTEGRILIN ® 64 oxybutynin ATD TM 64 Aganocide 64 bowel syndrome Non 64 Copegus R 64 AzaSite Xtra 64 FDA Accepts 64 rheumatoid arthritis osteoarthritis ankylosing 64 interferon beta 1a infertility 64 PROSTASCINT R 64 IMPDH inhibitor 64 humanized interleukin 6 64 PROVENGE sipuleucel T 64 Vitrasert R 64 Clolar ® 64 TRANSDUR Sufentanil 64 ORENCIA R 64 TOCOSOL Camptothecin 64 Phase III Trial 64 class mGluR5 inhibitor 64 granted Ortec 64 Q#IR 64 Wafer polifeprosan 64 Phase 1b clinical trials 64 ORENCIA ® 64 Thalomid ® 64 Biogen Genentech 64 Bezielle 64 pediatric Crohn disease 64 non nucleoside HCV 64 Keppra R 64 REMOXY POSIDUR ELADUR 64 sunitinib Sutent 64 FUSILEV ® 64 therapeutically inactive prodrug 64 tumor lysis syndrome 64 Behcet uveitis 64 VIAject R 64 Excellarate TM 64 diarrhea vomiting nausea 64 budesonide foam 64 Proquin XR 64 novel orally inhaled 64 nasal calcitonin product 64 Inhalation Solution 64 indiplon capsules 64 vaginal lidocaine 64 CYP#A# CYP#D# 64 ezogabine 64 Peginterferon alfa 2b 64 DexaSite 64 oral proteasome inhibitor 64 FACTIVE R gemifloxacin 64 HGS# 64 multicenter Phase III 64 ADVEXIN clinical 64 NEUPOGEN 64 IMiDs ® 64 Syncria R 64 TRIOLEX ™ 64 TMS Therapy 64 Kamada AAT 64 oxypurinol 64 ENL recurrence 64 please visit www.advaxis.com 64 pan HDAC inhibitor 64 elevated creatine phosphokinase 64 APTIVUS ritonavir 64 corticotropin injection 64 Submits Biologics License Application 64 PEG SN# 64 Asentar TM 64 Raptiva ® 64 TNF Tumor Necrosis Factor 64 neuromuscular spasm 64 oral leukoplakia 64 Dacetuzumab 64 Ozarelix 64 Ostarine ™ 64 tezampanel 64 TKB# 64 intravesical infusion therapy 64 unresectable malignant mesothelioma UMM 64 mu opioid receptor antagonist 64 MKC# MT 64 vaccines oncolytic virus 64 antidiabetic drug 64 unresectable HCC 64 Alpha interferons including 64 Kuvan sapropterin dihydrochloride 64 TAXUS Element Paclitaxel Eluting 64 Initiated Phase 64 Patients Treated With 64 Daclizumab 64 Mylan Receives Approval 64 sterile lidocaine patch 64 antiangiogenesis therapies 64 either acutely decompensated 64 sNDA submission 64 hyperplasia BPH 64 Hematide ™ peginesatide 64 JAK Inhibitor 64 CCR9 antagonist 64 vernakalant hydrochloride 64 Icatibant 64 alvespimycin 64 retinal vein occlusion RVO 64 candidate AQ4N 64 TM Aganocide 64 ongoing Phase IIIb 64 Nexavar prescribing 64 Factor VIIa 64 arsenic trioxide injection 64 Orally administered 64 memantine HCl 64 REVLIMID R 64 Ofatumumab 64 Cariprazine 64 Bone Graft 64 ELIQUIS 64 COLAZAL ® 64 ELADUR 64 Vascugel 64 sNDAs 64 specifically hypoactive sexual 64 reslizumab 64 PENTASA 64 evaluating mipomersen 64 acute peripheral arterial 64 Ketotransdel TM 64 JOULFERON 64 BARACLUDE R 64 Unit Dose Budesonide 64 Azedra ™ 64 LEVADEX TM 64 PROVIGIL 64 dacetuzumab SGN 64 PEGylated Fab fragment 64 candidate REP# 64 clinical trials dacetuzumab SGN 64 SUTENT ® 64 OvaRex R 64 overactive bladder syndrome 64 topical non steroidal 64 talactoferrin 64 Pimavanserin 64 serotonergic drugs 64 Combidex 64 Parkinson disease levodopa induced 64 HeFH 64 pharmacodynamic parameters 64 Cimzia TM 64 mertansine 64 dependent kinase inhibitor 64 induced mucositis 64 terlipressin 64 Aggrastat ® tirofiban hydrochloride 64 immuno inflammatory diseases 64 Ranolazine 64 overactive bladder AA# 64 5 HT3 antagonist 64 Chrysalin 63 visit www.targanta.com 63 ZYBRESTAT fosbretabulin 63 acne impetigo 63 huN# DM1 63 oral isoform selective HDAC 63 OMAPRO ™ 63 aplastic anemia AA 63 Hepatocellular Carcinoma HCC 63 Sanvar R 63 PEGylated anti 63 Testosterone MDTS ® 63 Diovan Exforge Tekturna Zelnorm 63 TRISENOX ® 63 phase IIb clinical 63 Glatiramer Acetate 63 topically applied SEPA 63 Catena ® 63 alemtuzumab MS 63 candidate SILENOR TM 63 ® pioglitazone HCl 63 castrate resistant prostate cancer 63 orally inhaled migraine 63 INTEGRILIN 63 tizanidine hydrochloride short 63 NPS NPS Pharmaceuticals 63 Files Investigational 63 HYVISC R 63 TM pralatrexate injection 63 FDA APPROVES 63 Prolongs Survival 63 IIIa inhibitor 63 KIACTA ™ 63 BUPHENYL 63 MGd 63 Cutaneous T 63 HP Acthar Gel repository 63 Phase #b/#a clinical 63 ZYFLO R 63 Ganite ® 63 beta 1a 63 confirmatory Phase III 63 pancreatic prostate 63 Telintra 63 AGILECT R 63 oral dual endothelin 63 StaphVAX R 63 Rebif ® 63 Fondaparinux 63 doxepin HCl 63 Chemophase 63 thalidomide Thalomid 63 Frozen Shoulder syndrome Adhesive 63 Solazed ™ 63 PORxin TM platforms 63 Second Pivotal Phase 63 visit www.sciclone.com 63 INC# 63 Phase Ib study 63 oncolytic virus therapies 63 FUSILEV enhances 63 GVAX ® 63 Vicinium TM 63 Boehringer Ingelheim MedImmune 63 Triolex 63 Submits Response 63 human C1 inhibitor 63 Fast Track Status 63 Safinamide 63 Injectable Bone Graft 63 MGCD# MGCD# [001] 63 induce orthostatic hypotension 63 Mg Uk 63 Alvine Pharmaceuticals 63 cromolyn sodium 63 Increlex R 63 novel emulsion formulation 63 thetreatment 63 Immunotherapeutic 63 hypertension osteoarthritis 63 Combination REOLYSIN R 63 Azedra TM Onalta TM 63 Augment ™ 63 metabolic disorders Saizen R 63 Somatuline R Autogel R 63 individualized cellular immunotherapy 63 Receives Approvable Letter 63 Exherin TM 63 Pegasys ® 63 Randomized Phase 63 TAFA# 63 TYGACIL 63 Palifosfamide 63 Eltrombopag 63 constipation predominant irritable bowel 63 keloid scarring 63 myeloproliferative diseases 63 Launches Generic Version 63 liver resection surgeries 63 Perforomist ™ Inhalation Solution 63 phenylalanine ammonia lyase 63 VNS Therapy TM 63 NP2 Enkephalin 63 Commences Phase 63 ostarine 63 bicifadine 63 dextofisopam 63 constipation OIC 63 Drug Candidate 63 Kuvan TM sapropterin 63 rusalatide acetate 63 ALGRX 63 sodium glucose cotransporter 63 RSD# iv 63 M# rationally 63 omecamtiv mecarbil formerly 63 Angiox ® 63 EDEMA3 63 receiving VELCADE 63 metastatic neuroendocrine tumors 63 baminercept 63 Leukine ® 63 cognitive impairment associated 63 Announces Tentative Approval 63 Ecallantide 63 monoclonal antibody conjugated 63 retinal vein occlusion 63 MYCAMINE 63 Liprotamase 63 Investigational Compound 63 please visit www.medicinova.com 63 pradefovir 63 OSMOPREP 63 SPARLON 63 Tarceva TM 63 ALVESCO R 63 Ketotransdel 63 myocardial infarction ventricular fibrillation 63 injectable depot 63 BEMA ® 63 diabetic peripheral neuropathic pain 63 aldehyde dehydrogenase ALDH2 deficiency 63 Mesafem 63 Therapeutic Competitors Companies 63 IBS C 63 myelofibrosis polycythemia vera 63 icatibant 63 ongoing Phase 1b 63 methylnaltrexone 63 Azedra TM 63 combines bupropion 63 markets XIFAXAN ® 63 Copegus ® 63 evaluating intravenous picoplatin 63 Refractory Hodgkin Lymphoma 63 GABITRIL 63 Expanded Indication 63 phase IIb study 63 oral transdermal 63 Dose Escalation 63 Inc. www.micromet inc.com 63 P#X# antagonist 63 lenalidomide Revlimid R 63 r hGH 63 cobiprostone 63 efficacy tolerability 63 Elotuzumab 63 DOR# 63 BRIM2 63 INCB# [001] 63 neutropenia thrombocytopenia 63 sitaxsentan 63 cinacalcet HCl 63 salmeterol inhalation powder 63 AERx R 63 AVAPRO 63 Phase 2a Clinical Trial 63 Cinryze ™ 63 IgG1 monoclonal antibody 63 Gets FDA Clearance 63 L BLP# 63 telomerase therapeutic 63 CONBRIZA 63 postsurgical pain 63 BEMA TM Fentanyl 63 opioid naive 63 Initiates Phase 2b 63 ® adefovir dipivoxil 63 Orphan Drug designations 63 Tß4 63 norepinephrine reuptake inhibitor 63 Triapine R 63 sertraline Zoloft 63 SinuNase ™ 63 Rescula 63 FDA Approvable Letter 63 Through Glycoscience 63 cardio renal 63 Fibrin Patch 63 Genentech Rituxan 63 receiving INTRON 63 R PEG uricase 63 XIAFLEX ™ 63 Phase IIIb 63 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 63 PEG PAL 63 R rilonacept Injection 63 SABER ™ 63 serotonin norepinephrine reuptake inhibitor 63 Peginterferon alfa 2a 63 allosteric modulator PAM 63 Firazyr 63 Surfaxin LS 63 DAVANAT 63 undergoing elective percutaneous 63 ORE# 63 Seliciclib 63 plus prednisone prednisolone 63 R roscovitine 63 Prospective Randomized 63 VYVANSE TM lisdexamfetamine 63 TOCOSOL Paclitaxel 63 Topline Results 63 Pooled Analysis 63 Dupuytren Contracture 63 PROGENSA R 63 hypercalcemia 63 POSIDUR TM ELADUR TM 63 IAP inhibitor 63 miconazole Lauriad ® 63 Neurodex 63 OvaRex ® MAb 63 Amrubicin 63 mild hepatic impairment 63 Angioedema 63 Cypher Sirolimus 63 Marketing Authorization Application 63 Central Retinal Vein 63 Benign Prostatic Hyperplasia 63 Aztreonam lysine 63 PDE# inhibitors 63 ODT metoclopramide HCl PEPCID 63 metformin sulfonylurea 63 worsening thrombocytopenia 63 ZOLINZA 63 trastuzumab Herceptin R 63 Proellex TM 63 midstage clinical 63 Ocrelizumab 63 Acute Ischemic Stroke 63 Soliris TM eculizumab 63 SARMs 63 ankle fusions 63 rufinamide 63 Amigal 63 Targretin capsules 63 www.telik.com 63 drug pipeline TAFA# 63 targeted radiotherapeutic 63 ULORIC 63 Peyronie disease Frozen Shoulder 63 Adjunctive Therapy 63 reduce serum phosphate 63 zileuton IV 63 novel topoisomerase 63 MoxDuo IR 63 ENABLE Phase 2 63 Vascular Disrupting Agent 63 Nasdaq PGNX today 63 acetylgalactosamine 6 63 LUNESTA ® 63 somnolence dizziness 63 NSAID induced GI 63 non constipating irritable 63 RECOTHROM R 63 ACAPODENE R 63 Rigel R# 63 Levulan ® PDT 63 d l leucovorin 63 Naglazyme R 63 prescribed proton pump 63 Trofex ™ 63 novel oral anticoagulant 63 Long Term Efficacy 63 candidates Augment ™ 63 Aloxi R 63 Rhucin ® recombinant 63 Serdaxin ® 63 CysDisplay R 63 Azedra 63 GW# [003] 63 Phase IIb clinical trials 63 Fibrin Pad 63 Phase Ib IIa 63 Therapeutic Competitors companiesandmarkets.com adEgemonye 63 TAXUS TM 63 MEND CABG 63 Phase IIb trials 63 dual endothelin receptor antagonist 63 Soriatane 63 Sciences ABthrax Albuferon 63 Granulocyte Colony Stimulating Factor 63 topical gel formulation 63 PDE4 inhibitor 63 Phase 2a clinical trials 63 Vitrasert ® 63 ICA # 63 sarcoma melanoma 63 THALOMID 63 HuCAL PLATINUM ® CysDisplay 63 * olmesartan medoxomil 63 NAVISTAR R 63 oxaliplatin Eloxatin 63 ziprasidone Geodon 63 headache abdominal pain 63 IRX 2 63 tubulin inhibitor 63 EVIZON TM 63 fibromyalgia syndrome 63 Lenocta 63 liposomal formulation 63 antiplatelet medications 63 subcutaneous formulation